A longitudinal study of one hundred consecutive admissions to the Royal Adelaide Hospital for carbon monoxide poisoning was conducted from 1986 to 1989. Twenty-five patients left hospital with persistent symptoms and signs of this poisoning. Five subsequently recovered. Twenty-four other patients, who were well when they left hospital, did not attend for a review one month after discharge. Extensive neuropsychiatric testing at this time showed 32% (24 of 76) had obvious sequelae of their exposure. Overall, the frequency of neuropsychiatric sequelae in the patients who only received oxygen at atmospheric pressure was 63% (N = 8) on discharge and 6 7% (N = 6) on one month follow-up. The frequency of sequelae among those who were given one hyperbaric oxygen treatment only was 46% (N = 24) on discharge and 50% (N = 20) on one month follow-up. In contrast, the frequency of sequelae in patients who had two or more hyperbaric oxygen treatments was only 13% (N = 68) on discharge (P< 0.005) and 18% (N = 50) on follow-up (P < 0.005). The frequency of sequelae was also significantly greater if hyperbaric oxygen was delayed (P < 0.05). No markers of severe poisoning could be identified.
domestic gases, carbon monoxide is still a common fatal poison. I Survivors are often left with neuropsychiatric deficits. 2 It is surprising then that the important toxic mechanisms of this poison are not understood and that the optimal treatment has not been established.
Oxygen has been proposed as a suitable antidote to carbon monoxide because an elevated oxygen tension will increase the amount of oxygen in solution in plasma, will compete with carbon monoxide for haemoprotein binding sites 3 and has been shown to inhibit the lipid peroxidation that follows a carbon monoxide exposure. 4 Only one prospective randomized controlled study of oxygen in carbon monoxide poisoning has been reported, S but the review of patient-outcome in this study was performed by many different physicians and did not include any psychometric assessment. Also, the various oxygen regimens used had previously been shown to be ineffective. 6 ,7 As a pilot to a prospective randomized controlled study of a wider range of oxygen doses, we conducted a longitudinal study (to account for patients who relapse or deteriorate after discharge)8,9 of one hundred consecutive admissions to our hospital for carbon monoxide poisoning. The patient review included extensive psychometric assessment because this is thought to be the most sensitive available measure of carbon monoxide morbidity. 7, 10 METHODS One hundred consecutive adult admissions to The Royal Adelaide Hospital (RAH) for carbon monoxide poisoning, from May 1, 1986 , to December 14, 1989 , were included in the study.
Children, patients dead on arrival and those patients in whom either the diagnosis was in doubt or other poisons were significantly involved, were excluded (twenty-one patients during this period),
The oxygen dose initially varied according to the patient's condition and the consulting physician's preferred regimen. However, normobaric oxygen Period (NBO) was discouraged after 1986 when most patients treated with this dose of oxygen were left with sequelae, either at discharge from hospital ( Figure 1 ) or at a one month follow-up ( Figure 2 ). Only one patient was given NBO after this time (July-December 1988, Figure 1 ); this patient was asymptomatic on admission to hospital and refused hyperbaric oxygen (HBO) treatment. Hyperbaric oxygen was administered for sixty minutes in a multiplace recompression chamber (RCC) at 2.8 Bars absolute pressure. The capabilities of this RCC have been described previously.ll Normobaric oxygen was administered, at atmospheric pressure, by tightsealing mask and at high oxygen flow rates through a breathing-circuit with a gas reservoir. Attendance at a follow-up clinic was encouraged. The review schedule consisted of a cardiologic, neurologic and psychometric assessment one month after discharge from hospital. The psychometric evaluation was performed by a psychologist who was unaware of the oxygen dose administered and included sub-tests of word reading, mental arithmetic, non-verbal problem- solving, abstract thinking, information-processing, psychomotor speed, verbal fluency, blockconstruction, symbol-copying, conceptual tracking, adaptive sorting, and especially, memory. Memory was variously tested by recalls of number sequences, both forwards and backwards, tests of current knowledge, and recall of geometric designs, object pictures, prose passages, lists and complex figures, both immediately and after a delay, and with attempts at intercurrent distraction. Scores were compared to those on other sub-tests, with relevant standards if they existed and to the patient's educational records. An electrocardiograph (ECG) was also recorded, and in some patients further investigations including CT brain scans, visual field mapping, electroencephalograph and electronystagmograph record, audiometry and evoked response studies were performed as clinically indicated. Sequelae were defined as early (morbidity evident at the time of discharge from hospital) or late (morbidity found at the one-month review that was not obvious when the patient was discharged from hospital). The carboxyhaemoglobin (COHb) percentage recorded was that measured in venous blood by carbon monoxide oximetry on admission to hospital; the percentage of patients with loss of consciousness included all patients who were unconscious at any time and not just at the time of admission to hospital; the frequency of intermittent positive pressure ventilation (IPPV) included only those patients who needed assisted ventilation on admission; and, the "delay prior to HBO" group included only those patients who were treated with HBO, but where such treatment was not begun within 10 hours of their final exposure to carbon monoxide.
Data were tested, where appropriate, by unpaired t tests or by calculation of Fisher's Exact P_value. 12 A significance level of P < 0.05 was chosen.
RESULTS
The sources of the hundred carbon monoxide poisonings are listed in Table 1 and the presenting symptoms and signs and other clinical features in Table 2 .
Eight patients were treated with NBO alone, 24 were given a single HBO treatment and 68 received two or more HBO treatments. There were no significant differences between the different oxygen-treatment groups with respect to presentation, other forms of management or the proportion of patients presenting for the onemonth review (Table 3) .
At the time of discharge from hospital, 25 of the 100 patients had persistent symptoms and signs (Figure 1) ; all attended the one month review, by which time 5 (20%) had experienced a complete resolution. Among the other 51 patients attending the one-month review, who were well when discharged, four (8%) had developed If only NBO or a single HBO treatment was given, the frequency of sequelae at both discharge (63 and 46%) and at one month follow-up (67 and 50%) was similar (Figures 1 and 2 ; Table 4 ). However, at either time, significantly fewer patients treated with two or more HBO treatments had any form of sequelae (P < 0.005) and/or were depressed or suffering a loss of higher mental function (P < 0.05) in comparison to those treated with either NBO or a single HBO treatment.
The 24 patients who did not attend the onemonth review had no obvious problems at the time of their discharge from hospital. These nonattenders did not differ significantly from those that did attend in terms of mean age (27.2 years SD 9), the COHb concentration measured on admission to hospital (16.4%, SD 12), the frequency of unconsciousness (63%), suicide attempts (71 %), or the type and timing of oxygen treatment.
Analysis of the remaining 76 patients who did present for the one month review, in the context of either having some or no sequelae, is displayed in Tables 5 and 6 . Delay prior to any HBO was associated with a significantly greater frequency (but no change in the type) of sequelae (P < 0.05).
However, the development or type of sequelae did not appear to be related to age, suicide attempts, the admission COHb concentration, a history of LOC, a need for IPPV, abnormal ECG findings or arterial gas tensions.
DISCUSSION
In this prospective and longitudinal study of one hundred consecutive admissions to RAH for carbon monoxide poisoning, 32% of the patients who were reviewed either did not experience a complete recovery or had a relapse. Morbidity, most commonly a loss of higher mental function and depression, was significantly greater among those who were treated with either NBO or a single HBO treatment and in those who did not receive any HBO within ten hours of the exposure. Depression was seen subsequently in patients both intentionally and accidentally exposed to carbon monoxide, but less often in those patients given two or more HBO treatments. These data are similar to those reported elsewhere and recently reviewed by Gorman and Runciman. 2 Also consistent with those reports is the observation here that many of our patients relapsed or recovered after their discharge from hospital. Therefore, a longitudinal design for any clinical study of carbon monoxide treatment is essential. Despite our best efforts to encourage patients to return for assessment, 24% of our patients still did not attend the one-month review.
Raphael et at. 5 attempted to resolve a similar problem of losses to follow-up by posting questionnaires to patients and by recruiting the support of family physicians. These practices are likely to introduce considerable bias as the questionnaires require patient insight and the involvement of many different family physicians will prevent consistent assessment and any sensitive psychometric testing. 7 • 10 There is no obvious solution to high non-attendance rates, and even if a thorough neuropsychiatric follow-up like ours is used, such subject losses in a longitudinal study makes data interpretation difficult. Again, similar to other reports,?,13 we have not been able to identify any early markers of severe carbon monoxide poisoning. This, together with the effect of delay prior to HBO and the apparent superiority of two or more HBO treatments, makes the seeking of ethics committee approval to test alternative n;:gimens to early and repeated HBO questionable.
There is an urgent need to identify a reliable marker of severe carbon monoxide poisoning and to test a wide range of oxygen doses, including different oxygen tensions, durations and exposuretimings, as alternative antidotes. The study reported here however demonstrates that a definitive study will not be easy to perform. Indeed, it is our intention to offer early and repeated HBO to victims of carbon monoxide poisoning until such time as fundamental in vitro and in vivo research demonstrate the important toxic mechanisms of carbon monoxide and/or a marker of severe poisoning is identified. 
